Rolls-Royce shares have recently pulled back to 966p from a year-to-date high of 1,011p, likely due to profit-taking ahead of its crucial July 31st earnings report, despite a 70% YTD gain. The company is anticipated to post strong results and potentially raise guidance, driven by robust demand across its civil aviation, power (fueled by AI), and defense segments, mirroring the strong performance of industry peers like GE Aerospace. While technical analysis suggests potential for further gains towards 1,100p, a bearish divergence in indicators also points to a possible downside to 900p, making the upcoming earnings release pivotal for the stock's direction.
Rolls-Royce Holdings (RYCEY) has experienced a modest pullback to 966p from a year-to-date high of 1,011p, a move attributed to profit-taking following a substantial 70% YTD gain. The company's fundamental outlook remains strong, supported by robust demand across its primary segments. In civil aviation, positive results from major airlines and significant order backlogs at Airbus and Boeing, coupled with GE Aerospace's strong 21% revenue growth and raised guidance, create a positive read-through for Rolls-Royce. The power systems division is also thriving, evidenced by a strong 1.5x book-to-bill ratio and growing demand linked to the AI boom, a trend reflected in the performance of peers like Siemens Energy and GE Vernova. While the company has maintained its operating profit guidance of £2.7 billion to £2.9 billion, the market anticipates a potential upward revision in the crucial July 31st earnings release. The technical picture presents a dichotomy: the stock remains in a firm ascending channel with a potential target of 1,100p, but a bearish divergence on the MACD and RSI indicators signals a risk of a correction towards 900p, making the upcoming earnings a pivotal event for the stock's direction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment